and received hormone manipulation with tamoxifen 20 mg daily. Four years later, while continuing adjuvant tamoxifen, she developed an isolated left supraclavicular nodal metastasis. This was confi rmed histologically, the tumour remaining ER positive and HER2 negative. Six cycles of epirubicin chemotherapy and high dose nodal radiotherapy achieved a complete response. She remained in remission for a further 5 years, but then presented with progressively worsening lethargy, anorexia, migraines and cough for 7 months.
INVESTIGATIONS
A whole body CT demonstrated a 6.0 cm×5.0 cm lobulated soft tissue density mass sitting astride the interatrial septum ( fi gure 1 ). No lymphadenopathy or other masses were seen.
Subsequent transthoracic and transoesophageal echocardiograms (TOEs) were performed, confi rming the mass to have a broad based attachment to the interatrial septum on both its right and left atrial aspects, the majority of the mass being within the left atrium ( fi gure 2 ). No associated valvular abnormality was seen and Doppler interrogation indicated blood fl ow within the lesion. Impaired diastolic fi lling of the right atrium was noted. Coronary angiography identifi ed the mass had a blood supply from both the left and right coronary arteries ( fi gure 3 ) making a neoplastic lesion most likely. Percutaneous, catheter-directed atrial biopsy was performed, confi rming malignancy, histologically identical to the primary breast lesion excised 9 years previously. This cardiac secondary maintained the original receptor profi le of ER positive ( fi gure 4 ) and HER2 negative.
DIFFERENTIAL DIAGNOSIS

Thrombosis
Coronary vegetation/abscess Atrial myxoma Primary sarcoma Secondary malignant tumour.
This case describes a 55-year-old lady presenting with lethargy, migraines and a cardiac mass on a background history of breast cancer. She had been treated initially with a mastectomy, axillary node clearance, reconstruction and hormone manipulation followed by chemotherapy and high dose radiotherapy for an isolated supraclavicular metastases. She was disease free for 5 years when she complained of lethargy and migraines. A CT confi rmed an isolated cardiac lesion, confi rmed on echocardiogram A percutaneous atrial biopsy revealed an atrial metastases from breast carcinoma. She was treated with chemotherapy achieving a good response but was still deemed inoperable after treatment. She currently is receiving letrozole.
Figure 1 Axial CT image showing atrial mass lesion (red arrow).
TREATMENT
The patient was commenced on docetaxel chemotherapy to achieve tumour shrinkage and symptom control. She was started on letrozole on completion of her cytotoxic therapy.
OUTCOME AND FOLLOW-UP
To monitor the effectiveness of treatment, 2-weekly transthoracic echocardiograms were performed. A dramatic reduction in the size of tumour occurred after only 2 weeks of chemotherapy ( fi gure 2 ) and the patient's symptoms of lethargy and migraines improved signifi cantly. Follow-up CT after four cycles confi rmed shrinkage of the tumour with the maximum diameter of 3.9 cm from 6 cm. On completion of chemotherapy the patient was started on letrozole 2.5 mg daily. Recent cardiac review confi rms continued shrinkage of the tumour and a positron emission tomography scan has confi rmed no other metastatic disease. Cardiothoracic opinion was sought but despite the absence of other metastasis, the tumour was deemed inoperable.
DISCUSSION
In patients with known malignant disease, secondary spread to the heart is a distinctly unusual complication although occasional postmortem studies have shown a higher rate than clinically suspected. 1 The most common offending primary site is the lung. 2 Usually, cardiac secondaries are silent with symptoms from other metastatic disease more prominent. When deposits are multiple the diagnosis, in the clinical context, is straight forward but if the cardiac lesion is solitary -a range of differential diagnoses apply. Principal alternatives include thrombosis, vegetations or primary tumours. 1 3 Considering the latter, atrial myxomas and primary sarcomas are the commonest. Cardiac metastases are rarely a solitary phenomenon, but here we report such a case. Metastatic disease in breast cancer is not uncommon and usually affects the skeletal system, liver and lungs and, more commonly in triple negative and HER2 positive disease, the brain. A single cardiac secondary without other visceral deposits is most unusual. Right-sided cardiac lesions are more suspicious for malignancy because metastatic disease spreads to the right heart due to the venous drainage. 1 4 Clinical features of cardiac secondaries vary according to their position within the heart. Intracavitary tumours can cause embolic phenomena, constitutional symptoms such as fever, fatigue and weight loss and obstructive symptoms, such as syncope, whereas myocardial tumours cause atrial or ventricular arrhythmias and even sudden death. 1 3 Pericardial involvement can lead to pericardial effusion and tamponade causing the patient to experience signifi cant clinical symptoms. 1 3 5 Migraines are not documented as a clinical symptom from cardiac masses and our report is therefore the fi rst to document such an occurrence.
Figure 2 Echocardiogram showing large atrial mass straddling the interatrial septum (red arrow). Transoesophageal echocardiogram (top). Prechemo transthoracic echocardiography (TTE) (bottom left). Postchemo TTE (bottom right).
For cardiac lesions, echocardiogram is the fi rst diagnostic test of choice. It is non-invasive, does not expose the patient to ionising radiation, allows real time analysis and can be allied to functional and haemodynamic assessments with Doppler. When the lesion is located in one or both of the atria, TOE is often benefi cial as in this case. 3 Our patient had a CT fi rst which was useful in searching for distant metastases, assessing local infi ltration of the cardiac mass and can provide an alternative view if echocardiography is technically challenging. 3 5 Despite our recognition that CT was most useful in this case we did use echocardiograms regularly initially to assess tumour response and cardiac function. This was a quick, instant, non-invasive method of monitoring and enabled us to rule out pericardial effusion and obstruction of the atrioventricular valves.
The percutaneous biopsy, being the only approach available to obtain a tissue diagnosis, was performed to rule out atrial myxoma. Solid nests of mild to moderately pleomorphic cells with small nuclei were seen amidst fragments of the myocardium. Immunohistochemistry was performed to distinguish the source of these tumour cells and MNF116 was positive, indicating an epithelial origin. 6 Nuclear staining was seen for the ER and the cells were negative for thyroid transcription factor 1, synaptophysin and WT-1, all of which is compatible with metastases from a breast carcinoma. 6 As in all cases of metastatic breast cancer, systemic treatment was the modality of choice in a fi t patient. The size and position of the tumour made surgery and radiotherapy impossible. The patient had previously progressed through hormonal treatment and had responded well to epirubicin. Single agent taxane chemotherapy was therefore given. After the fi rst cycle of chemotherapy her migraines had become signifi cantly less frequent, her energy and appetite improved.
Learning points
▶ Biopsy is vital in confi rming diagnosis of an atrial mass Cardiac metastases are relatively common and as ▶ clinicians we should be more aware of these as they can cause a signifi cant range of symptoms including migraine A multidisciplinary approach to a complex case is ▶ essential for diagnosis and management. Please cite this article as follows (you will need to access the article online to obtain the date of publication). 
